We found that the groups treated with LyeTx I-b and carboplatin did not exhibit statistical significance in VEGF concentration (pg/mL) of primary tumor and lung tissues (Figure 12A), while these compounds induced a significant reduction in TGF-β expression level in primary tumor and spleen compared to the control (Figure 12B). The gene discussed is VEGFA; the disease is neoplasm.